Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immunocore Holdings (IMCR) Net Margin (2023 - 2025)

Historic Net Margin for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to 0.19%.

  • Immunocore Holdings' Net Margin fell 110800.0% to 0.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.71%, marking a year-over-year increase of 81800.0%. This contributed to the annual value of 16.47% for FY2024, which is 57000.0% up from last year.
  • Per Immunocore Holdings' latest filing, its Net Margin stood at 0.19% for Q3 2025, which was down 110800.0% from 10.51% recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Net Margin registered a high of 10.89% during Q3 2024, and its lowest value of 590.9% during Q4 2021.
  • For the 5-year period, Immunocore Holdings' Net Margin averaged around 109.9%, with its median value being 26.98% (2022).
  • Per our database at Business Quant, Immunocore Holdings' Net Margin skyrocketed by 5652200bps in 2022 and then tumbled by -110800bps in 2025.
  • Quarter analysis of 5 years shows Immunocore Holdings' Net Margin stood at 590.9% in 2021, then soared by 96bps to 25.68% in 2022, then dropped by -9bps to 28.12% in 2023, then dropped by -1bps to 28.28% in 2024, then soared by 99bps to 0.19% in 2025.
  • Its last three reported values are 0.19% in Q3 2025, 10.51% for Q2 2025, and 5.31% during Q1 2025.